HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Te-Chun Hsia Selected Research

Methyltransferases

9/2015Cantharidin induces DNA damage and inhibits DNA repair-associated protein levels in NCI-H460 human lung cancer cells.
1/2014Bufalin induces cell death in human lung cancer cells through disruption of DNA damage response pathways.
4/2012Induction of DNA damage by deguelin is mediated through reducing DNA repair genes in human non-small cell lung cancer NCI-H460 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Te-Chun Hsia Research Topics

Disease

82Neoplasms (Cancer)
04/2024 - 05/2003
62Lung Neoplasms (Lung Cancer)
05/2024 - 01/2003
44Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 10/2008
17Neoplasm Metastasis (Metastasis)
04/2024 - 03/2008
17Asthma (Bronchial Asthma)
01/2024 - 01/2003
13Adenocarcinoma of Lung
01/2024 - 05/2012
12Carcinogenesis
07/2023 - 11/2008
8Inflammation (Inflammations)
01/2024 - 01/2003
8Leukemia
09/2022 - 03/2005
8Breast Neoplasms (Breast Cancer)
01/2017 - 04/2012
7Disease Progression
01/2023 - 10/2008
6Prostatic Neoplasms (Prostate Cancer)
01/2023 - 12/2005
6Glioblastoma (Glioblastoma Multiforme)
10/2022 - 04/2016
5Stomach Neoplasms (Stomach Cancer)
01/2024 - 05/2005
5Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 01/2014
4Diarrhea
02/2024 - 02/2021
4Mouth Neoplasms (Oral Cancer)
11/2022 - 01/2017
4Glioma (Gliomas)
09/2022 - 06/2009
4Urinary Bladder Neoplasms (Bladder Cancer)
09/2018 - 02/2005
4Mitochondrial Diseases (Mitochondrial Disease)
01/2017 - 05/2011
3Edema (Dropsy)
04/2024 - 08/2016
3Infections
01/2024 - 08/2007
3Adenocarcinoma
09/2023 - 01/2017
3Osteosarcoma (Osteogenic Sarcoma)
12/2022 - 12/2005
3Brain Neoplasms (Brain Tumor)
01/2022 - 01/2017
3Respiratory Insufficiency (Respiratory Failure)
01/2021 - 01/2014
3Hypertension (High Blood Pressure)
01/2020 - 06/2011
3Ataxia Telangiectasia (Louis Bar Syndrome)
11/2018 - 04/2012
3Oncogene Addiction
01/2018 - 11/2013
3Triple Negative Breast Neoplasms
01/2014 - 04/2013
3Colonic Neoplasms (Colon Cancer)
09/2013 - 12/2005
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2013 - 09/2008
3Pneumothorax
01/2012 - 05/2003
3Liver Neoplasms (Liver Cancer)
07/2010 - 12/2005
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2009 - 03/2008

Drug/Important Bio-Agent (IBA)

31ErbB Receptors (EGF Receptor)IBA
04/2024 - 10/2008
29Tyrosine Kinase InhibitorsIBA
04/2024 - 10/2008
22Proteins (Proteins, Gene)FDA Link
04/2024 - 12/2005
16DNA (Deoxyribonucleic Acid)IBA
04/2024 - 05/2003
14Biomarkers (Surrogate Marker)IBA
04/2024 - 10/2011
14Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2023 - 10/2008
11CaspasesIBA
01/2023 - 12/2008
11Matrix Metalloproteinases (MMPs)IBA
09/2021 - 12/2009
11Gefitinib (Iressa)FDA Link
01/2020 - 11/2010
9CytokinesIBA
03/2022 - 01/2003
8AfatinibIBA
02/2024 - 05/2012
7Messenger RNA (mRNA)IBA
01/2018 - 05/2003
6Caspase 3 (Caspase-3)IBA
09/2022 - 02/2006
6Reactive Oxygen Species (Oxygen Radicals)IBA
03/2021 - 03/2008
6PlatinumIBA
02/2021 - 06/2011
5Matrix Metalloproteinase 2 (Gelatinase A)IBA
03/2024 - 11/2012
5Matrix Metalloproteinase 7 (Matrilysin)IBA
01/2023 - 12/2017
5Genetic Markers (Genetic Marker)IBA
09/2022 - 01/2003
5Pemetrexed (MTA)FDA Link
02/2021 - 06/2011
5bufalinIBA
04/2017 - 01/2014
5Cantharidin (Cantharides)IBA
11/2016 - 11/2010
4osimertinibIBA
01/2024 - 01/2020
4Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
01/2024 - 07/2016
4SmokeIBA
11/2023 - 01/2014
4Phosphotransferases (Kinase)IBA
01/2023 - 04/2013
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 11/2015
4Cytochromes c (Cytochrome c)IBA
01/2013 - 11/2009
4CurcuminIBA
02/2010 - 05/2003
4AcetyltransferasesIBA
12/2005 - 05/2003
4N-acetyltalosaminuronic acid (NAT)IBA
12/2005 - 05/2003
3Bevacizumab (Avastin)FDA Link
01/2023 - 06/2011
3bisdemethoxycurcuminIBA
12/2022 - 01/2022
3PhytochemicalsIBA
09/2022 - 12/2008
3Immune Checkpoint InhibitorsIBA
01/2022 - 12/2019
3GemcitabineFDA Link
02/2021 - 06/2011
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2017
3Antineoplastic Agents (Antineoplastics)IBA
07/2020 - 08/2011
3Cisplatin (Platino)FDA LinkGeneric
04/2020 - 06/2011
3benzyl isothiocyanateIBA
09/2018 - 08/2011
3deguelinIBA
01/2018 - 04/2012
3phenethyl isothiocyanate (PEITC)IBA
01/2018 - 05/2011
3FlavonoidsIBA
01/2017 - 02/2006
3EnzymesIBA
07/2016 - 01/2004
3Interleukin-10 (Interleukin 10)IBA
11/2015 - 01/2003
3MethyltransferasesIBA
09/2015 - 04/2012
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2015 - 04/2012
3Lapatinib (GW572016)FDA Link
01/2014 - 04/2013
3NF-kappa B (NF-kB)IBA
11/2013 - 05/2005
3diallyl disulfide (diallyl disulphide)IBA
09/2013 - 09/2008
3amsonic acid (DAS)IBA
09/2013 - 06/2011
3allyl sulfideIBA
09/2013 - 06/2011
3Caspase 9IBA
08/2011 - 11/2009
3endonuclease GIBA
01/2011 - 10/2009
3Apoptosis Inducing FactorIBA
01/2011 - 10/2009
3AnthraquinonesIBA
01/2011 - 11/2009
3aloe emodinIBA
11/2009 - 12/2005
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2024 - 03/2008
2CreatinineIBA
04/2024 - 01/2023

Therapy/Procedure

30Therapeutics
01/2024 - 05/2010
14Drug Therapy (Chemotherapy)
09/2023 - 06/2011
12Radiotherapy
01/2024 - 11/2014
4Chemoradiotherapy
06/2022 - 09/2014
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 08/2011
3Hyperbaric Oxygenation
03/2024 - 02/2009
3Catheters
01/2012 - 08/2007